Lee Seo-Young, Lee So-Ryoung, Choi Eue-Keun, Kwon Soonil, Yang Seokhun, Park Jiesuck, Choi You-Jung, Lee Hyun-Jung, Moon Inki, Lee Euijae, Han Kyung-Do, Cha Myung-Jin, Oh Seil, Lip Gregory Y H
Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea.
Department of Internal Medicine Seoul National University College of Medicine Seoul Republic of Korea.
J Am Heart Assoc. 2021 Aug 17;10(16):e020901. doi: 10.1161/JAHA.121.020901. Epub 2021 Aug 7.
Backgroud There is a paucity of information on whether changes in metabolic syndrome (MetS) status affect the risk of new-onset atrial fibrillation (AF). We aimed to evaluate whether changes in MetS status and components of MetS affect AF risk using data from a nationwide observational cohort. Methods and Results A total of 7 565 531 adults without prevalent AF (mean age, 47±14 years) who underwent 2 serial health examinations by the Korean National Health Insurance Cooperation were identified. The patients were categorized into 4 groups according to the change in MetS status in serial evaluations, as follows: patients with persistent MetS (n=1 388 850), healthy patients newly diagnosed with MetS in the second evaluation (n=608 158), patients with MetS who were healthy in the second evaluation (n=798 555), and persistently healthy individuals (n=4 769 968). During a mean 7.9-year follow-up, incident AF was diagnosed in 139 305 (1.8%) patients. After multivariable adjustment, the AF risk was higher by 31% in the patients with persistent MetS , 26% in the patients with MetS who were healthy in the second evaluation, and 16% in the healthy patients newly diagnosed with MetS in the second evaluation compared with the persistently healthy individuals. Regardless of the MetS component type, the AF risk correlated with changes in the number of components. The risk of AF was strongly correlated with MetS status changes in the young and middle-age groups (20-39 years and 40-64 years, respectively) than in the elderly group (≥65 years). Conclusions Dynamic changes in MetS status and persistent MetS were associated with an increased risk of AF in a large-scale Asian population.
关于代谢综合征(MetS)状态的变化是否会影响新发房颤(AF)的风险,目前信息匮乏。我们旨在利用全国性观察队列的数据,评估MetS状态及其组成成分的变化是否会影响房颤风险。
共纳入7565531例无房颤病史的成年人(平均年龄47±14岁),这些人接受了韩国国民健康保险合作组织的两次连续健康检查。根据连续评估中MetS状态的变化,将患者分为4组,具体如下:持续性MetS患者(n = 1388850)、在第二次评估中新诊断为MetS的健康患者(n = 608158)、在第二次评估中健康的MetS患者(n = 798555)以及持续健康个体(n = 4769968)。在平均7.9年的随访期间,139305例(1.8%)患者被诊断为新发房颤。多变量调整后,与持续健康个体相比,持续性MetS患者的房颤风险高31%,在第二次评估中健康的MetS患者高26%,在第二次评估中新诊断为MetS的健康患者高16%。无论MetS组成成分类型如何,房颤风险均与组成成分数量的变化相关。与老年组(≥65岁)相比,年轻和中年组(分别为20 - 39岁和40 - 64岁)的房颤风险与MetS状态变化的相关性更强。
在大规模亚洲人群中,MetS状态的动态变化和持续性MetS与房颤风险增加相关。